SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

The ever increasing popularity of marijuana in United States has prompted most of the companies’ active in this field to take their operations to the next level. Amongst tens of other companies, Medican Enterprises Inc (OTCMKTS:MDCN) has also decided to strengthen its operations. Reports claim that the company has got approval to carry out marijuana operation in Arizona Property.

Insights On The Matter:

Medical Enterprises announced that the government had given approval to carry out marijuana operations to a 67,000 square foot facility, situated in Arizona. Reports claim that Medican is on the verge of buying the same property to expand its operations. The news has come as a double bonanza for the company as it will not only be able to run existing project in a comfortable way, but also execute marijuana related operations without any hassle.

After the approval, the Arizona Property can run various operations related to production of medical marijuana. Senior Management Team of the company is delighted to announce this news. According to Ken Williams, Chief Executive Officer, Medican Enterprises Inc (OTCMKTS:MDCN), it’s something the company had been expecting for a long time. Arizona Property meets all the minimum requirements that Medican Enterprises seeks for.

Williams hopes to finish the due-diligence as soon as possible to ensure that the buying procedure doesn’t last long. The property is situated just a few minutes away from the I-17 and Hwy 60. The Arizona Property has most of the amenities that are needed around it, which makes it an ideal property to run operations.

Reporters tried to get in touch with the representatives of the company to get some more insights of the transaction, but they didn’t succeed. The execution of this transaction is expected to take place by the end of 2015’s first quarter. Management of the company is hopeful that this decision will prove to be beneficial in the near future.